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Abstract In this study we have examined the correlation 
between activity o f erythropoiesis and serum concentra-
tions o f erythropoietin and insulin-like growth factor I in 
male and female rats dur ing accelerated growth (day 
30-90). We found that fractional incorporation o f i ron 
into newly formed red blood cells was linearily correlated 
with body weight gain. Total i ron incorporation into 
newly formed red blood cells reflecting total daily red cell 
formation increased almost linearily between day 25 and 
80 after birth in both sexes. While serum erythropoietin 
concentrations decreased in the time interval investigated 
(25-120 days), serum IGF-I levels increased in both sexes 
between day 25 and 55. In this period, individual values 
of total i ron incorporation into red blood cells and serum 
IGF-I concentrations were linearily correlated. O u r ob-
servations support the concept that IGF-I rather than 
erythropoietin modulates erythropoiesis dur ing acceler-
ated growth and thus manages a proportional increase in 
body mass and oxygen transport capacity. 
It is well established that red cell mass increases in 
strict proportion to the body mass during the 
growth period of mammals (1). This proportional-
ity is physiologically important because it ensures 
that increased oxygen consumption is matched by 
an increased oxygen transport capacity. However, 
the way by which this adaptation is brought about 
is unknown. Since erythropoiesis in the adult is pri-
marily controlled by erythropoietin (2), one could 
assume that this hormone is of major importance 
also within this growth process. Another candidate 
for the adapation is insulin-like growth factor I. 
IGF-I is considered to mediate the growth promot-
ing activities of growth hormone (3) and thus to 
govern growth of the organism. IGF-I has been 
found to enhance the proliferation of erythroid 
precursors in vivo (4) and in vitro (5-8). Recent 
evidence indicates that application of IGF-I to hy-
pophysectomized rats leads to a proportional sti-
mulation of erythropoiesis and body growth (9). 
The relation between the rate of erythropoiesis and 
serum levels of IGF-I and erythropoietin in intact 
animals during the growth period is unknown. In 
order to distinguish possible roles of IGF-I and ery-
thropoietin in the regulation of erythropoiesis 
during growth we have determined 5 9Fe incorpo-
ration into red blood cells, serum IGF-I, and serum 
erythropoietin levels in normal growing rats. 
The results obtained are supportive to the con-
cept that erythropoiesis during growth is governed 
by IGF-I. 
Materials and Methods 
Animals 
Sprague-Dawley rats (Ivanovas, Kissleg, FRG) were bred 
and grown in the local animal house. T h e animals had 
free access to standard chow (Altromin®) and water. 
Weights o f animals were controlled daily at noon. 
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59Fe-incorporation into red blood cells 
Rates o f erythropoiesis were determined by measuring 
iron incorporation into newly formed red blood cells. 
Rats were injected ip with 2uGi/100 g 5 9 Fe-chloride (spe-
cific activity 10uGi/ng); 48 h after the injection the rats 
were anesthesized with ether and bled by heart puncture. 
T h e 48-h interval was chosen to avoid interference with 
age-dependency of i ron kinetics (10). B lood was collected 
in non-heparinized plastic tubes. Serum was stored at 
— 20°C. T h e fractional : , 9 Fe incorporation into red blood 
cells (RBC) was calculated according to the following gen-
erally used formula: 5 0 F e incorporation (%) = (radioac-
tivity per ml o f blood) X blood volume (ml) X 100/(total 
radioactivity injected). B lood volume was calculated ac-
cording to published data (I). Total ; ' 9 Fe incorporation 
into R B C was calculated as (total radioactivity injected) x 
5 9 F e incorporation (%)/100. 
Determination of serum erythropoietin concentrations 
Serumerythropoietin levels were determined by radio-
immunoassay as described previously (11). Erythropoie-
tin-enriched rat serum was used as standard which had 
been calibrated in the exhypoxic mouse assay for erythro-
poietin (11). Eadh sample was measured in duplicate. 
Determination of serum IGF-I concentrations 
Serum I G F I was determined by radioimmunoassay (12) 
using rabbit antiserum batch 6656/251074 (gift from late 
D r Reber, Hoffmann-La Roche, Basel, C H ) against 
human IGF-I (final di lution 1:20 000). IGF-I was sepa-
rated from I G F carrier proteins by gel permeation on a 
Sephadex G-50 column in 1 mol/1 acetic acid. Separated 
I G F was lyophilized and stored at - 2 0 ° C . After reconsti-
tution with 1 ml PBS, p H 7.4, containing 0.1% (w/v) 
human serum albumin, all samples were assayed at 3 dif-
ferent dilutions. 
Results 
The development of body mass of Sprague-Dawley 
rats with aging is characterized by a sigmoidal curve 
(Fig. 1). A period of accelerated growth occurs be-
tween the 30th and 80th day after birth in both 
sexes. In this period, body weight gain ranges be-
tween 4.4 and 7,4 g/day in male and between 3.4 
and 4.7 g/day in female rats. The age dependency 
of body weight gains for both sexes is shown in Fig. 
1 (insert). 
As indices for the activity of erythropoiesis both 
fractional and total : ) 9Fe incorporation into newly 
formed red blood cells were determined. Frac-
tional 5 9Fe incorporation was considered to reflect 
the specific activity of erythropoietic tissues (re-
lated to constant body mass), whereas total 59Fe in-
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Fig. 1. 
Body weight of male and female Sprague-Dawley rats as a function of age. Weights were determined daily. The values 
are shown for different ages as mean ± SEM (N = 20 to 30 for both sexes). Lines between the means were drawn by 
inspection (•) male, (o) female. 
Insert: body weight gain (b.w.g.) at different ages for male (•) and female (o) rats. 
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Fractional (upper panel) and total (lower panel) o 9 F e in-
corporation into newly formed red «jlood cells (RBC) in 
male (•) and female (o) rats at different ages. Data are 
mean ± SEM (N = 9 to 12 for both sexes). 
corporation reflects the absolute amount of red 
cells formed. The fractional incorporation rate of 
59Fe into red blood cells had a value of around 57% 
for both sexes at day 25 after birth (Fig. 2 upper 
panel) and declined to a value of around 30% with 
increasing age. 5 9Fe incorporation rates in male an-
imals decreased at a slower rate than those of 
female rats. Fractional 5 9Fe incorporation rates and 
body weight gain were linearily correlated in both 
sexes (59Fe incorporation (%) = 28.1 + 3.2 x body 
weight gain (g/day); r = 0.95). The total incorpo-
ration of 5 9Fe into red blood cells increased almost 
linearily between day 30 and 70 (Fig. 3 lower panel) 
and approached a plateau with increasing age. The 
plateau in male rats was about 70% higher than that 
reached in female animals. 
Serum-erythropoietin concentrations in both 
sexes decreased with increasing age in the time in-
terval investigated (day 25-120) (Fig. 3, upper 
panel). Serum IGF-I concentrations on the other 
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F,g.3. 
Immunoreactive serum erythropoietin (Epo) (upper 
panel) and serum IGF-I concentrations of male (•) and 
female (o) rats at different ages. Data are mean ± SEM 
(N = 7 to 9 for both sexes). 
hand increased almost linearily during the phase of 
growth acceleration (Fig. 3, lower panel). Starting 
from the same level at day 25, IGF-I increased to 
around 135 ug/1 in male and to around 95 ug/1 in 
female rats. After the phase of accelerated growth, 
IGF-I levels tended to fall slightly in both sexes. In 
Fig. 4 the correlation between individual serum 
IGF-I levels and total rates of iron incorporation 
during the period of accelerated growth is shown. 
Both parameters are linearily correlated. 
Discussion 
In this study we have investigated the correlation 
between the activity of erythropoiesis, serum ery-
thropoiesis, and serum IGF-I levels in growing rats. 
The results show that fractional 5 9Fe incorporation, 
indicating specific erythropoietic activity, declines 
steadily from the neonatal period and onwards 
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Relationship of individual values for total incorporation 
of 5 9 Fe into newly formed red blood cells to serum IGF-I 
levels in rats dur ing accelerated growth. Linear regres-
sion as indicated by the dashed line: total r>'*Fe incorpo-
ration (cpm 10~6) = -0 .266 + 0.0166 X [IGF-I] (ng/1); 
r = 0.81, p<0.0001. (•) male, (o) female animals. 
(Fig. 2). This fall of iron incorporation rates is at-
tenuated during the phase of accelerated growth, 
which occurs between 30 and 80 days after birth 
(Fig. 1). After the neonatal period, fractional 5 9Fe 
incorporation rates were linearily correlated to the 
body weight gains. This observation supports the 
concept that fractional , 9Fe incorporation rates re-
flect the sum of red cell formation necessary to 
compensate daily red cell degradation and to refill 
the daily expanding circulatory system. Extrapola-
tion of the linear regression curve yielded a frac-
tional '"'Fe incorporation of 28% for non-growing 
animals. This value is similar to the 0 9Fe incorpo-
ration rates of growth-arrested, hypophysecto-
mized rats (9) determined under comparable ex-
perimental conditions. 
Total red cell formation is reflected by the total 
incorporation of iron (Fig. 2, lower panel). The 
curve obtained fits well with direct calculations of 
daily red cell formation in rats during growth (1). 
Red cell formation increased by a factor of around 
10 and 6 in male and female rats, respectively, 
during the period of accelerated growth. This in-
crease in red cell formation was associated with a 
fall of serum erythropoietin levels (Fig. 3, upper 
panel). The observed decrease of serum erythro-
poietin with age is in accordance with observations 
by Clemons et al. (13) and Bozzini et al. (14), who 
also found a difference in serum erythropoietin 
between neonatal and adult rats. Most likely this 
decrease of erythropoietin formation is caused by 
recovery from the anemia which develops during 
the neonatal period, and which is completely com-
pensated 70 days after birth in rats (1). 
Considering the inverse relationship of serum 
erythropoietin to total red cell formation during 
accelerated growth, it seems unlikely that erythro-
poietin only governs the expansion of red cell 
volume in this period. The conclusion is in accord-
ance with previous observations (15, 16) that ery-
thropoiesis during rapid growth cannot be blunted 
by plethora, a condition which is known to suppress 
erythropoietin formation in the adult (17). Re-
cently it has been shown that plethora in fact blunts 
erythropoietin formation but not the erythropoie-
tic activity present in the serum of mice during 
rapid growth (18). 
The temporal relation between IGF-I levels and 
body weight gain as observed in this study is in 
accordance with the concept that IGF-I governs the 
increase in body and organ mass during acceler-
ated growth (3). Our findings show that red cell 
formation and serum IGF-I concentrations are also 
directly correlated during accelerated growth (Fig. 
4). It is tempting to speculate therefore that IGF-I 
causes proliferation and expansion of hemopoietic 
tissues in proportion to the increase of body mass. 
Although our findings cannot prove a causality, 
they could provide an essential link in the under-
standing of a possible role of IGF-I in the regula-
tion of erythropoiesis during growth. Whether this 
effect is mediated by systemic IGF-I or by locally 
released IGF-I (19) cannot be answered yet. 
The present results show that red cell formation 
and body weight gain are linearily correlated, and 
that the individual rates of red cell formation are 
directly correlated with serum IGF-I levels. Re-
cently it was demonstrated that infusion of IGF-I 
into growth-arrested hypophysectomized rats 
causes a proportional increase in growth and ery-
thropoiesis (9). IGF-I, moreover, has been shown to 
enhance the proliferation of erythroid precursors 
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in vivo (4) and in vitro (5-8). In addition, the ex-
istence of IGF-I receptors on erythroid precusors 
(20) as well as the existence of IGF-I in the direct 
environment of erythroid precursors have been 
demonstrated in vivo (21). The sum of these ob-
servations supports the idea that IGF-I governs 
erythropoiesis during the period of accelerated 
growth and thus manages a proportional increase 
in body mass and oxygen transport capacity. 
Such a role of IGF-I would not contest an essen-
tial involvement of erythropoietin in the mainte-
nance of erythropoiesis in growing animals as sug-
gested by a recent study (14). In fact, there is some 
evidence that IGF-I requires the presence of ery-
thropoietin for its mitogenic effect on erythroid 
precusors from adult mammals (6-8). A modular 
tory role of IGF-I on erythropoiesis maintained by 
erythropoietin would also be supported by recent 
findings that serum erythropoietin levels do not 
change during puberty in humans (22, 23), a situ-
ation in which IGF-I levels rise and red cell masses 
expand. 
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